Q'Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neurovascular Access System

The Armadillo Neurovascular Access System with SelectFlex™ Technology delivers the versatility required for physicians to confidently tackle a wide range of neurovascular interventions. Regardless of access site, the low-profile 7F catheter enables a biaxial approach to accelerate delicate interventions and eliminate the complexity and cost of conventional tri-axial configurations. The Armadillo Neurovascular Access System with SelectFlex™ Technology delivers the versatility...

The Armadillo Neurovascular Access System with SelectFlex™ Technology delivers the versatility required for physicians to confidently tackle a wide range of neurovascular interventions. Regardless of access site, the low-profile 7F catheter enables a biaxial approach to accelerate delicate interventions and eliminate the complexity and cost of conventional tri-axial configurations.

"The Armadillo Neurovascular Access System with SelectFlex™ Technology addresses the shortcomings of currently available neurovascular access catheters. We believe it provides a novel option that allows hospitals to standardize device usage, decrease inventory constraints and reduce cost per procedure," stated Jodie Fam, CEO of Q'Apel Medical. "I thank our incredible team for their efforts to achieve this critical milestone. We look forward to building upon Armadillo's U.S. commercial success as we prepare to expand our international portfolio and deliver this meaningful solution to the European market, and others, in the coming months."

About Q'Apel Medical:

Q'Apel Medical��is revolutionizing neurovascular interventions. Inspired by the evolving needs of our customers, our novel approach allows us to solve clinical challenges where others fall short. We are up for the task, the more complex the better. Our team thrives on creating high quality uniquely engineered products, designed in partnership with neurovascular specialists, that address what is needed right now, yet with the versatility to focus on what is coming next. For more information, visit www.qapelmedical.com.

Media Contact:
Charlene Herndon
SPRIG Consulting
[email protected]

Photo - https://mma.prnewswire.com/media/2595956/I_am_Armadillo.jpg

 

View original content:https://www.prnewswire.co.uk/news-releases/qapel-medical-announces-ce-mark-approval-for-armadillo-selectflex-neurovascular-access-system-302349303.html